OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)
Clinical trial NCT02097121 · TERMINATED
Trial details
- NCT number
- NCT02097121
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-23
- Primary completion
- 2022-02-10
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.